Concomitant pulmonary vein isolation with pentaspline pulsed-field ablation and left atrial appendage occlusion via internal jugular venous approach: First US report

Percutaneous atrial fibrillation (AF) ablation, regardless of energy source utilized, is being widely used as an effective way of treating atrial fibrillation. Pulmonary vein isolation (PVI) remains the cornerstone of any ablation procedure. Percutaneous left atrial appendage (LAA) closure has emerged as an effective stroke prevention strategy in AF patients who have high thromboembolic risk but cannot tolerate long-term anticoagulation. The combined approach of atrial fibrillation ablation and left atrial appendage occlusion (LAAO) in a single procedural setting has recently received approval from the Centers for Medicare & Medicaid Services (CMS).